Deal Sucker
  • Vetted
  • Shopping Tips & Hacks
    • Automotive
    • Electronics & Tech
  • Travel & Outdoor
    • Home & Garden
  • Health & Wellness
    • Pets
    • Finance & Money-Saving
    • Parenting & Kids
    • Fashion & Beauty
  • About
    • Disclaimer
    • Contact Us

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025

Categories

  • Automotive
  • Automotive & Garage
  • Electronics & Tech
  • Fashion & Beauty
  • Finance & Money-Saving
  • Fitness & Wellness
  • Furniture & Decor
  • General
  • Health & Wellness
  • Home & Garden
  • Home & Kitchen
  • Home Improvement
  • Outdoor & Backyard
  • Parenting & Family
  • Parenting & Kids
  • Pets
  • Shopping Tips & Deals
  • Shopping Tips & Hacks
  • Travel & Lifestyle
  • Travel & Outdoor
  • Vetted
Deal Sucker
  • Vetted
  • Shopping Tips & Hacks
    • Automotive
    • Electronics & Tech
  • Travel & Outdoor
    • Home & Garden
  • Health & Wellness
    • Pets
    • Finance & Money-Saving
    • Parenting & Kids
    • Fashion & Beauty
  • About
    • Disclaimer
    • Contact Us

Browsing Category

Health & Wellness

52 posts
  • Health & Wellness

Roche’s Collaborator MediLink Announces Phase III Data For Tam-Peli Showing Significantly Improved Overall Survival In Chinese Patient Population With Relapsed Small-cell Lung Cancer

Roche’s Collaborator MediLink Announces Phase III Data For Tam-Peli Showing Significantly Improved Overall Survival In Chinese Patient Population With Relapsed Small-cell Lung Cancer
MediLink reports significant overall survival improvement in phase III trial of Tam-Peli for relapsed small-cell lung cancer in Chinese patients, boosting interest.
  • Deal Sucker Team
  • September 13, 2026
View Post
  • Health & Wellness

Australian GPs Promise Faster Specialist Access Amid Appointment Dispute

Australian GPs Promise Faster Specialist Access Amid Appointment Dispute
Australian general practitioners pledge to expedite specialist referrals for urgent cases, amid ongoing dispute over appointment guarantees and healthcare access.
  • Deal Sucker Team
  • September 12, 2026
View Post
  • Health & Wellness

Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of LEQEMBI® (Lecanemab) For Early Alzheimer’s Disease

Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of LEQEMBI® (Lecanemab) For Early Alzheimer’s Disease
Canada’s drug regulator issues final positive review supporting public reimbursement of Leqembi® for early Alzheimer’s disease, marking a significant policy shift.
  • Deal Sucker Team
  • September 1, 2026
View Post
  • Health & Wellness

HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China

HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China
HUTCHMED announces SANOVO trial showing notable progression-free survival benefits with ORPATHYS® plus TAGRISSO® in lung cancer patients in China.
  • Deal Sucker Team
  • August 31, 2026
View Post
  • Health & Wellness

Hanmi Pharm Signs Exclusive Licensing Deal With Genentech For Novel Obesity Therapy

Hanmi Pharm Signs Exclusive Licensing Deal With Genentech For Novel Obesity Therapy
Hanmi Pharm has entered an exclusive licensing agreement with Genentech to develop and commercialize a novel obesity therapy, marking a significant step in obesity treatment.
  • Deal Sucker Team
  • August 24, 2026
View Post
  • Health & Wellness

Anbogen Therapeutics And The University Of Tokyo Enter Collaborative Research Agreement To Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion

Anbogen Therapeutics And The University Of Tokyo Enter Collaborative Research Agreement To Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
Anbogen Therapeutics and The University of Tokyo have announced a collaborative research agreement to evaluate ABT-301 across multiple tumor types, aiming to accelerate clinical development.
  • Deal Sucker Team
  • August 24, 2026
View Post
  • Health & Wellness

Kura Oncology Announces Publication In Blood Highlighting Ziftomenib’s Differentiated Binding Profile And Preclinical Activity

Kura Oncology Announces Publication In Blood Highlighting Ziftomenib’s Differentiated Binding Profile And Preclinical Activity
Kura Oncology announced a new publication in Blood highlighting Ziftomenib’s unique binding profile and preclinical activity, marking a potential advancement in AML treatment.
  • Deal Sucker Team
  • August 10, 2026
View Post
  • Health & Wellness

HanchorBio And Taiwan Cancer Moonshot Project-NTU Subteam Led By Professor Sung-Liang Yu Establish Strategic Collaboration To Advance Precision Oncology

HanchorBio And Taiwan Cancer Moonshot Project-NTU Subteam Led By Professor Sung-Liang Yu Establish Strategic Collaboration To Advance Precision Oncology
HanchorBio partners with Taiwan Cancer Moonshot Project-NTU Subteam led by Professor Sung to advance cancer treatment research through strategic collaboration.
  • Deal Sucker Team
  • August 10, 2026
View Post
  • Health & Wellness

AI-empowered Pipeline-in-a-drug Option: Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, As Preclinical Candidate (PCC) For Ocular Diseases, Inflammatory Disorders And Aging

AI-empowered Pipeline-in-a-drug Option: Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, As Preclinical Candidate (PCC) For Ocular Diseases, Inflammatory Disorders And Aging
Insilico Medicine has announced ISM9077 as a preclinical candidate for ocular, inflammatory, and aging diseases, leveraging AI-driven drug discovery.
  • Deal Sucker Team
  • August 6, 2026
View Post
  • Health & Wellness

THE STORK FOUNDATION FOR INFERTILITY OPENS 2026 GRANT APPLICATIONS TO EASE FINANCIAL BURDEN OF IVF TREATMENTS

THE STORK FOUNDATION FOR INFERTILITY OPENS 2026 GRANT APPLICATIONS TO EASE FINANCIAL BURDEN OF IVF TREATMENTS
The Stork Foundation for Infertility has announced opening of grant applications for 2026 to help reduce the financial burden of IVF treatments.
  • Deal Sucker Team
  • August 1, 2026
View Post
Record War Spending, A Stalled Economy: Can Putin Afford 2027? The Bell Webinar — November 2, 2026
  • Finance & Money-Saving

Record War Spending, A Stalled Economy: Can Putin Afford 2027? The Bell Webinar — November 2, 2026

The Bell’s Nov. 2 webinar will examine Russia’s record military spending, economic…
  • Deal Sucker Team
  • October 27, 2026
15 Best Halloween Skeleton Lawn Decorations for Spooky Outdoor Displays in 2027
  • Vetted

15 Best Halloween Skeleton Lawn Decorations for Spooky Outdoor Displays in 2027

Compare 15 Halloween skeleton lawn decorations, from compact stakes to life-size…
  • Deal Sucker Team
  • October 27, 2026
The Overlooked Opportunities In Emerging Markets
  • Finance & Money-Saving

The Overlooked Opportunities In Emerging Markets

Barings manager Adnan El-Araby argues investors should look beyond major Asian markets…
  • Deal Sucker Team
  • October 27, 2026
outdoor cooking equipment comparison
  • Outdoor & Backyard

Grill vs Smoker vs Pizza Oven for Backyard Entertaining

When choosing between a grill, smoker, or pizza oven for backyard entertaining,…
  • Deal Sucker Team
  • October 27, 2026
Deal Sucker
  • Impressum
  • Affiliate Disclosure
  • Terms of Use
  • Privacy Policy
  • About DealSucker.com
  • Disclaimer
Copyright © 2026 Deal Sucker Content on Deal Sucker is created and published using artificial intelligence (AI) for general informational and educational purposes. Affiliate disclaimer As an affiliate, we may earn a commission from qualifying purchases. We get commissions for purchases made through links on this website from Amazon and other third parties.